 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Roche to Phase out Chip-Based Sequence Capture; Peptide Arrays 'Close' to Commercialization
October 02, 2012
Roche to Phase out Chip-Based Sequence Capture; Peptide Arrays 'Close' to Commercialization
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Array Firms Debut New Products to Cash in on 'Lucrative' Sequence-Capture Market
July 14, 2009 / BioArray News - Eli Lilly Taps SeqWright to Use Roche NimbleGen and 454 Tools in Psychiatric Diseases Study
August 4, 2009 / BioArray News - NEJM Papers Support Use of Arrays in Prenatal Dx as Sequencing Gains Ground
December 11, 2012 / BioArray News - Autism-Associated Variants Uncovered by Population Diagnostics, SickKids Team Could Yield Dx Tests
December 11, 2012 / BioArray News - Illumina Predicts Flat Future for Array Business as GWAS Decline Counters Growth in New Markets
October 30, 2012 / BioArray News